AJP Legacy AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol 228: 1341-1345, 1975;
0002-9513/75 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winder, W.
Right arrow Articles by Holloszy, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winder, W.
Right arrow Articles by Holloszy, J.
American Journal of Physiology, Vol 228, Issue 5, 1341-1345
Copyright © 1975 by American Physiological Society

ARTICLES

Effects of thyroid hormone administration on skeletal muscle mitochondria

WW Winder, KM Baldwin, RL Terjung, and JO Holloszy

The effects of thyroid hormone administration on the levels of a number of mitochondrial markers were measured in skeletal muscle and liver of normal rats. Injection of 18 mug of L-thyroxine (T4) per 100 g body wt every 4th day for 3 wk had no effect on the concentrations of cytochrome c, on citrate synthase activity, or on respiratory capacity of skeletal muscle. Injection of 200 mug of L-triiodothyronine (T3) daily for 5 days, or feeding 23 mg T4 and 7 mg T3/kg of diet for 2 wk, resulted in thyrotoxicosis and large increases in the activity of hepatic alpha-glycerophosphate dehydrogenase and other mitochondrial markers; however, the levels of activity of mitochondrial marker enzymes in gastrocnemius and quadriceps muscles were not significantly changed. Only when rats were fed 3 mg T4 and 1 mg T3/kg diet for a 6-wk period did we observe an increase in skeletal muscle mitochondrial markers. Thus, thyroxine treatment must be sufficiently prolonged if it is to be used as a tool for studying skeletal muscle mitochondrial biogenesis.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
D. J. Branvold, D. R. Allred, D. J. Beckstead, H. J. Kim, N. Fillmore, B. M. Condon, J. D. Brown, S. N. Sudweeks, D. M. Thomson, and W. W. Winder
Thyroid hormone effects on LKB1, MO25, phospho-AMPK, phospho-CREB, and PGC-1{alpha} in rat muscle
J Appl Physiol, October 1, 2008; 105(4): 1218 - 1227.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
B. N. Finck and D. P. Kelly
Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1 (PGC-1) Regulatory Cascade in Cardiac Physiology and Disease
Circulation, May 15, 2007; 115(19): 2540 - 2548.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. E. Sheehan, P. A. Kumar, and D. A. Hood
Tissue-specific regulation of cytochrome c oxidase subunit expression by thyroid hormone
Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E968 - E974.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
K. BAAR, Z. SONG, C. F. SEMENKOVICH, T. E. JONES, D.-H. HAN, L. A. NOLTE, E. O. OJUKA, M. CHEN, and J. O. HOLLOSZY
Skeletal muscle overexpression of nuclear respiratory factor 1 increases glucose transport capacity
FASEB J, September 1, 2003; 17(12): 1666 - 1673.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1975 by the American Physiological Society.